Stochastic epigenetic outliers can define field defects in cancer

BMC Bioinformatics

Research Article

Andrew E. Teschendorff¹  Martin Widschwendter²  Allison Jones² 

[1] CAS Key Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, China;Statistical Cancer Genomics, Paul O’Gorman Building, UCL Cancer Institute, University College London, 72 Huntley Street, WC1E 6BT, London, UK;Department of Women’s Cancer, University College London, 74 Huntley Street, WC1E 6AU, London, UK;Department of Women’s Cancer, University College London, 74 Huntley Street, WC1E 6AU, London, UK;

关键词: DNA methylation;    Field defect;    Cancer;    EWAS;    Differential variability;    Differential methylation;    Stochastic;   

DOI  :  10.1186/s12859-016-1056-z

 received in 2015-12-19, accepted in 2016-04-16,  发布年份 2016

来源: Springer

【 摘 要 】

BackgroundThere is growing evidence that DNA methylation alterations may contribute to carcinogenesis. Recent data also suggest that DNA methylation field defects in normal pre-neoplastic tissue represent infrequent stochastic “outlier” events. This presents a statistical challenge for standard feature selection algorithms, which assume frequent alterations in a disease phenotype. Although differential variability has emerged as a novel feature selection paradigm for the discovery of outliers, a growing concern is that these could result from technical confounders, in principle thus favouring algorithms which are robust to outliers.ResultsHere we evaluate five differential variability algorithms in over 700 DNA methylomes, including two of the largest cohorts profiling precursor cancer lesions, and demonstrate that most of the novel proposed algorithms lack the sensitivity to detect epigenetic field defects at genome-wide significance. In contrast, algorithms which recognise heterogeneous outlier DNA methylation patterns are able to identify many sites in pre-neoplastic lesions, which display progression in invasive cancer. Thus, we show that many DNA methylation outliers are not technical artefacts, but define epigenetic field defects which are selected for during cancer progression.ConclusionsGiven that cancer studies aiming to find epigenetic field defects are likely to be limited by sample size, adopting the novel feature selection paradigm advocated here will be critical to increase assay sensitivity.

【 授权许可】

CC BY   
© Teschendorff et al. 2016